ORCID as entered in ROS

Select Publications
McNeil HP; Krilis SA; Chesterman CN, 2020, 'Arterial Thrombosis—Diagnosis and Management', in Phospholipid-Binding Antibodies, CRC Press, pp. 191 - 203, http://dx.doi.org/10.1201/9780429278129-15
Qi M; Weaver JC; Rahgozar S; Giannakopoulos B; Krilis SA, 2019, 'Quantitation of total and free thiol angiotensinogen as a prognostic marker for preeclampsia', in Functional Disulphide Bonds : Methods and Protocols, pp. 285 - 293, http://dx.doi.org/10.1007/978-1-4939-9187-7_18
Qi M; Weaver JC; Krilis SA; Giannakopoulos B, 2019, 'Quantitation of total and free Thiol β
Willis R; Cohen H; Giles I; Knight JS; Krilis SA; Rahman A; de Groot PG, 2017, 'Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis', in Antiphospholipid Syndrome, Springer International Publishing, pp. 77 - 116, http://dx.doi.org/10.1007/978-3-319-55442-6_5
de Groot PG; de Laat B; Rand J; Vlachoyiannopoulos PG; El-Assaad F; Krilis SA; Giannakopoulos B, 2017, 'Natural Proteins Involved in Antiphospholipid Syndrome', in Antiphospholipid Syndrome, Springer International Publishing, pp. 15 - 27, http://dx.doi.org/10.1007/978-3-319-55442-6_2
Ioannou Y; Krilis SA, 2011, 'CHAPTER 52 Laboratory Testing for Antiphospholipid Syndrome', in Systemic Lupus Erythematosus, Elsevier, pp. 985 - 1000, http://dx.doi.org/10.1016/b978-0-12-374994-9.10052-x
Giannakopoulos B; Yan XK; Krilis S, 2007, 'Antibodies and their antigenic targets in the antiphospholipid syndrome', in Murphy K; Ray M (ed.), A Companion to Rheumatology: Systemic Lupus Erythematosus, Mosby Elsevier, USA, pp. 233 - 240, http://dx.doi.org/10.1016/B978-0-323-04434-9.50028-2
Giannakopoulos B; Yan X; Krilis SA, 2007, 'Chapter 22B Antibodies and their Antigenic Targets in the Antiphospholipid Syndrome', in Systemic Lupus Erythematosus, Elsevier, pp. 233 - 240, http://dx.doi.org/10.1016/b978-0-323-04434-9.50028-2
Reddel SW; Krilis S, 2002, 'The Anti-Phospholipid Syndrome', in Theofilopoulos CA; Bona AN (ed.), The Molecular Pathology of Autoimmune Diseases, edn. Second, Taylor & Francis, USA, pp. 325 - 352
Reddel SW; Krilis S, 2001, 'Antiphospholipid syndrome', in Austen ; Frank ; Atkinson ; Cantor (ed.), Sampter`s Immunologic Diseases, edn. sixth, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 571 - 579
Li L; Reddel SW; Krilis S, 2000, 'Phenotypic similarities and differences between human basophils and mast cells', in Mast cells adn Basophils in Physiology, Pathology and Host Defence, edn. Original, Academic Press, San Diego, California
Li L; Reddel SW; Krilis SA, 2000, 'The Phenotypic Similarities and Differences Between Human Basophils and Mast Cells', in Mast Cells and Basophils, Elsevier, pp. 97 - 116, http://dx.doi.org/10.1016/b978-012473335-0/50009-x
Li L; Zhang X; Krilis S, 1999, 'Factors that affect humkan mast cell and basophil growth', in Signal transduction in mast cells and basophils, edn. Original, Springer Publishing Company, Berlin, pp. 54 - 65
Li Y; Li L; Krilis S, 1997, 'Growth factors modulating human mast cell growth and function', in Seminars in Clinical Immunology, edn. Original, Edizioni Grafiche Mazzucchelli S.B.L., Italy, pp. 17 - 24
Kandiah DA; Krilis S, 1996, 'Immunology and methods of detection of antiphospholipid antibodies', in The antiphospholipid syndrome, edn. Original, CRC Press, Boca Raton, pp. 29 - 48
Hunt J; Krilis , 1994, 'Immunology of Antiphospholipid Antibodies', in Panayi GS (ed.), Immunology of the Connective Tissue Diseases, Kluwer Academic Pub
Krilis S; Lewis RA; Corey EJ; Austen KF, 1983, 'Determinants for an Integrated Tissue Response to the Sulphidopeptide Leukotrienes', in Proceedings of Invited Symposia, Palgrave Macmillan UK, pp. 3 - 9, http://dx.doi.org/10.1007/978-1-349-17072-2_1